Delivery Order SPE2DR25D3304-SPE2DR26F48E4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,398.71 to AmerisourceBergen Drug Corp for Junel FE 1.5 mg-30 mcg tablets (28-count package). This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of September 24, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Junel FE 1.5 mg–30 mcg tablets in quantities of 28, valued at $7,365.86. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The work is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,747.10 to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packages) on August 7, 2025, with a completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,453.52 on December 5, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in quantities of 28 units. The contract represents a firm fixed-price, non-set-aside delivery order with performance completion scheduled for December 8, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.20 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages). This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and has an ultimate completion date of August 25, 2025. The delivery order was issued on August 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) under a firm fixed-price contract. The award, valued at $1,388.16, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 12, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,076.91 to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) on November 20, 2025, with completion targeted for November 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single pharmaceutical delivery under the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order valued at $3,570.36 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets (28-count packages). This firm fixed price, non-set-aside delivery order is scheduled for completion by August 20, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $2,046.60 delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order valued at $1,904.40 to AmerisourceBergen Drug Corp for Junel FE 1 mg–20 mcg tablets (28-count packages) on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- SPE2DR25D3304Indefinite Delivery Contract
- SPE2DR25D3304-SPE2DR26F48E4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,934.32 to AmerisourceBergen Drug Corp for Junel FE 1.5 mg-30 mcg tablets (28-count packages). This non-set-aside, competitively awarded contract was issued on December 29, 2025, with an ultimate completion date of December 30, 2025, and reflects a firm fixed price delivery arrangement. The pharmaceutical product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime contract vehicle designated SPE2DX and extending through December 2026 that serves as the comprehensive global pharmaceutical support mechanism for federal military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, continues to fulfill critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this expansive contract vehicle. The company's extensive portfolio of federal medical procurement demonstrates its capability to deliver diverse pharmaceutical products—ranging from specialty medications and vaccines to generic and brand-name drugs—across multiple therapeutic domains to support military healthcare operations worldwide. This individual delivery order represents one transaction within the broader strategic relationship that positions AmerisourceBergen as a primary pharmaceutical vendor for federal defense medical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/28/25 |